Llovet, Josep M.
Zucman-Rossi, Jessica
Pikarsky, Eli
Sangro, Bruno
Schwartz, Myron
Sherman, Morris
Gores, Gregory
Article History
First Online: 14 April 2016
Competing interests
: J.M.L. receives research support and grants from Bayer Pharmaceuticals, Blueprint Medicines, Bristol-Myers Squibb and Boehringer Ingelheim, and is a consultant for Bayer Pharmaceuticals, Bristol-Myers Squibb, Blueprint Medicines, Eli Lilly and Company, Celsion, Biocompatibles, Boehringer Ingelheim, Novartis and GlaxoSmithKline. M.Sh. is a consultant for Bayer Pharmaceuticals, Celsion, ArQule, H3 Biomedicine and Merck. J.Z.-R. is a consultant for IntegraGen. B.S. has received lecturing and consulting fees from Bayer Healthcare and Sirtex Medical. G.G. is in the Data Safety and Monitoring committee for a Bayer Pharmaceuticals trial in hepatocellular carcinoma. M.Sc. and E.P. have nothing to disclose.